Nrx Pharmaceuticals Stock Technical Analysis
NRXP Stock | USD 1.31 0.01 0.77% |
As of the 3rd of December, NRX Pharmaceuticals secures the Risk Adjusted Performance of (0.08), market risk adjusted performance of 0.5183, and Mean Deviation of 2.91. Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of NRX Pharmaceuticals, as well as the relationship between them.
NRX Pharmaceuticals Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as NRX, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to NRXNRX |
NRX Pharmaceuticals Analyst Consensus
Target Price | Advice | # of Analysts | |
3.08 | Strong Buy | 3 | Odds |
Most NRX analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand NRX stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of NRX Pharmaceuticals, talking to its executives and customers, or listening to NRX conference calls.
NRX Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
NRX Pharmaceuticals Technical Analysis
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of NRX Pharmaceuticals volatility. High ATR values indicate high volatility, and low values indicate low volatility.
NRX Pharmaceuticals Trend Analysis
Use this graph to draw trend lines for NRX Pharmaceuticals. You can use it to identify possible trend reversals for NRX Pharmaceuticals as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual NRX Pharmaceuticals price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.NRX Pharmaceuticals Best Fit Change Line
The following chart estimates an ordinary least squares regression model for NRX Pharmaceuticals applied against its price change over selected period. The best fit line has a slop of 0.0091 , which may suggest that NRX Pharmaceuticals market price will keep on failing further. It has 122 observation points and a regression sum of squares at 3.16, which is the sum of squared deviations for the predicted NRX Pharmaceuticals price change compared to its average price change.About NRX Pharmaceuticals Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of NRX Pharmaceuticals on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of NRX Pharmaceuticals based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on NRX Pharmaceuticals price pattern first instead of the macroeconomic environment surrounding NRX Pharmaceuticals. By analyzing NRX Pharmaceuticals's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of NRX Pharmaceuticals's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to NRX Pharmaceuticals specific price patterns or momentum indicators. Please read more on our technical analysis page.
NRX Pharmaceuticals December 3, 2024 Technical Indicators
Most technical analysis of NRX help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for NRX from various momentum indicators to cycle indicators. When you analyze NRX charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.08) | |||
Market Risk Adjusted Performance | 0.5183 | |||
Mean Deviation | 2.91 | |||
Coefficient Of Variation | (842.46) | |||
Standard Deviation | 3.95 | |||
Variance | 15.61 | |||
Information Ratio | (0.15) | |||
Jensen Alpha | (0.37) | |||
Total Risk Alpha | (1.07) | |||
Treynor Ratio | 0.5083 | |||
Maximum Drawdown | 19.8 | |||
Value At Risk | (6.12) | |||
Potential Upside | 6.51 | |||
Skewness | 0.2968 | |||
Kurtosis | 1.89 |
Additional Tools for NRX Stock Analysis
When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.